Pancreatic cancer news
We investigate organoids, the latest way that scientists are growing cancer cells in the lab to help test hundreds of cancer drugs.
Cancer Research UK scientists are developing a bubbly drink packed with oxygen microbubbles to make treatments more potent for hard to treat tumours.
An extra 13 percent of pancreatic cancer patients will live for at least five years when given a combination of chemotherapy drugs.
Glasgow researchers have shown an experimental drug that blocks CXCR2 can improve survival in mice when given with immunotherapy drugs.
Research published today in Cancer Cell might open up a way through pancreatic tumours’ defences.